ArticleFrontiers in aging neuroscience2025

Subcutaneous foslevodopa/foscarbidopa initiation in a Parkinson's day-clinic - a suitable setting to ensure treatment efficacy, tolerability and psychosocial adaption.

Alina Jander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.